Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000711377-10-000049)

Filing Details

Accession Number:: 0000711377-10-000049
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-11-02 13:16:01
Reporting Period:: 2010-10-29

Filing Date:: 2010-11-02
Accepted Time:: 2010-11-02 13:16:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711377	Neogen Corp	NEOG	In Vitro & In Vivo Diagnostic Substances (2835)	382367843

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1189021	Edward Bradley		Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-10-29	2,160	$8.18	111,680	No	4	M	Direct
Common Stock	Disposition	2010-10-29	2,160	$33.63	109,520	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Option (Right to buy)	Disposition	2010-10-29	2,160	$0.00	2,160	$8.18

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
21,855		2010-10-31	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	14,012	Indirect	See Footnote

Footnotes

Held in Neogen Corporation 401-K Savings Plan
The options were granted 10/31/05 and became exercisable 20% yearly thereafter